Results 101 to 110 of about 62,128 (323)

Comparison of pH and Viscosity of Unstimulated Saliva in Type 2 Diabetic Patients and Control Group

open access: yesJournal of Dental School, 2019
Objectives: Diabetes mellitus is one of the most common chronic diseases that may cause irreversible complications. This disease can affect the salivary glands and oral health.
Azra Mohiti   +2 more
doaj   +1 more source

A multi-center, double-blind, randomized, placebo-controlled trial protocol to assess Traumeel injection vs dexamethasone injection in rotator cuff syndrome : the TRAumeel in ROtator cuff syndrome (TRARO) study protocol [PDF]

open access: yes, 2015
Background: Shoulder pain is a common musculoskeletal symptom with a wide range of potential causes; however, the majority of conditions can be managed with conservative treatment.
Vanden Bossche, Luc, Vanderstraeten, Guy
core   +2 more sources

Implementing a behavioural intervention for paediatric type 1 diabetes: Key informant perspectives of multilevel barriers and facilitators

open access: yesDiabetic Medicine, EarlyView.
Providers, healthcare leaders, adolescents and caregivers identified evidence of intervention effectiveness in lowering glycaemic levels as a key facilitator of implementing a type 1 diabetes behavioural intervention. Critical barriers to implementation include buy‐in among clinic leaders, resource availability within clinics and meeting families ...
Julia Price   +6 more
wiley   +1 more source

Serum cystatin C and chemerin levels in diabetic retinopathy [PDF]

open access: yes, 2017
Peer reviewedPublisher ...
Chen, Xuedong   +5 more
core  

Glycemic Control Patterns and Kidney Disease Progression among Primary Care Patients with Diabetes Mellitus [PDF]

open access: yes, 2011
Background: Reducing glycosylated hemoglobin (HbA1c) to near or less than 7% in patients with diabetes is associated with diminished microvascular complications, but this level is not consistently achieved.
Cummings, Doyle M.   +5 more
core   +1 more source

Glucocorticoid‐Induced Hyperglycaemia in Hospital: The Insulin Dose Matters Most

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Prescription of glucocorticoids in hospital is a common cause of new onset hyperglycaemia, which is associated with increased mortality and morbidity. However, to date studies have not defined optimal treatment of hyperglycaemia associated with glucocorticoids and this is reflected in clinical guidelines.
Morton G. Burt   +3 more
wiley   +1 more source

Comparative Predictive Value of Three Visceral Adiposity Indices for Cardiovascular Disease: A 17.5‐Year Korean Cohort Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Cardiovascular diseases (CVD) are the leading cause of death worldwide, with excess visceral adipose tissue (VAT) being identified as an independent indicator of poor cardiovascular outcomes. We examined the association between three indices of VAT, namely, metabolic score for visceral fat (METS‐VF), visceral adiposity index (VAI), and ...
A‐Ra Cho   +3 more
wiley   +1 more source

Effect of cinnamon on glycemic control and insulin resistance in type II diabetes patients: A randomized clinical trial [PDF]

open access: yes
Background & Objectives: Different types of diets and several chemical and herbal drugs are used for decreasing the fasting blood glucose, glycosylated hemoglobin and insulin resistance in type II diabetic patients.
خادم حقیقیان, حسین   +4 more
core  

Discontinuation of SGLT2i After a Urogenital Infection: A Population‐Based Matched Cohort Study of Patients With Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Sodium‐glucose cotransporter 2 inhibitors (SGLT2is) improve glycaemic control and cardiorenal outcomes in Type 2 diabetes, particularly in patients at elevated cardiovascular and kidney risk, yet discontinuation following infections appears common.
Christine Ljungberg   +5 more
wiley   +1 more source

Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed‐Dose Titration of Weekly Insulin Efsitora in Insulin‐Naïve Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims In the QWINT‐1 phase 3 Trial, once‐weekly insulin efsitora alfa (efsitora) administered using an innovative fixed‐dose regimen demonstrated noninferior HbA1c reduction versus once‐daily insulin glargine U100 (glargine) over 52 weeks in insulin‐naïve adults with type 2 diabetes.
Lisa Connery   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy